StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet. If you are pregnant, do not take StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet without a doctor's advice.
Is the use of StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet safe during breastfeeding?
StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet may have very limited harmful effects for breastfeeding women.
What is the effect of StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet on the Kidneys?
StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet rarely affects the kidneys.
What is the effect of StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet on the Liver?
Side effects of StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet rarely affect the liver.
What is the effect of StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet on the Heart?
Side effects of StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet rarely affect the heart.
StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet unless your doctor advises you to do so -
Is this StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet habit forming or addictive?
No, there is no any evidence that StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet is addictive.
Interaction between Food and StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet
Some foods when eaten with StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet
Consult your doctor before consuming alcohol while taking StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet as it can have severe side effects.
Yes, StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet can affect fertility. As per clinical studies, fertility defect was found in animal models, human clinical trial on fertility is still pending. You should take precaution while taking medicine during pregnancy. However, it is best to inform the doctor before taking these two medicines together.
StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet is a prescription drug so do not take it without consulting doctor. It can be harmful for the patient to take this medicine without a doctor's advice.
It is recommended to avoid taking StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet with ibuprofen because of the concurrent use of these two medicines can reduce the antihypertensive activity of StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet. It also decreases the renal blood flow. Please consult your doctor before taking these two medicines at the same time.
Yes, StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet causes a cough. It is a common side effect of this drug. However, if you experience a severe cough after taking this medicine then inform the doctor and follow his/her instructions.
StayHappi Olmesartan Medoxomil + Metoprolol Succinate ER Tablet is mainly used to treat high blood pressure (hypertension). Treating high blood pressure helps in reducing the complications of heart attacks, strokes, and kidney damages. It is also used to treat chest pain (angina).
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173